New Strong Buy Stocks for June 25th

By Zacks Equity Research | June 25, 2025, 6:16 AM

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

Bilibili BILI: This company which provides online videos, live broadcasting and mobile games in China, has seen the Zacks Consensus Estimate for its current year earnings increasing 21.4% over the last 60 days.

Bilibili Inc. Sponsored ADR Price and Consensus

Bilibili Inc. Sponsored ADR Price and Consensus

Bilibili Inc. Sponsored ADR price-consensus-chart | Bilibili Inc. Sponsored ADR Quote

Agnico Eagle Mines AEM: This company which is a gold producer with mining operations in Canada, Mexico and Finland, and exploration activities in Canada, Europe, Latin America and the United States, has seen the Zacks Consensus Estimate for its current year earnings increasing 16.1% over the last 60 days.

Agnico Eagle Mines Limited Price and Consensus

Agnico Eagle Mines Limited Price and Consensus

Agnico Eagle Mines Limited price-consensus-chart | Agnico Eagle Mines Limited Quote

Evercore EVR: This company which is a premier global independent investment banking advisory firm, has seen the Zacks Consensus Estimate for its current year earnings increasing 11.6% over the last 60 days.

Evercore Inc Price and Consensus

Evercore Inc Price and Consensus

Evercore Inc price-consensus-chart | Evercore Inc Quote

Veeva Systems VEEV: This company which offers cloud-based software applications and data solutions for the life sciences industry, has seen the Zacks Consensus Estimate for its current year earnings increasing 3.6% over the last 60 days.

Veeva Systems Inc. Price and Consensus

Veeva Systems Inc. Price and Consensus

Veeva Systems Inc. price-consensus-chart | Veeva Systems Inc. Quote

BioCryst Pharmaceuticals BCRX: This company which is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections, has seen the Zacks Consensus Estimate for its next year earnings increasing 78.3% over the last 60 day.

BioCryst Pharmaceuticals, Inc. Price and Consensus

BioCryst Pharmaceuticals, Inc. Price and Consensus

BioCryst Pharmaceuticals, Inc. price-consensus-chart | BioCryst Pharmaceuticals, Inc. Quote

 

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
BioCryst Pharmaceuticals, Inc. (BCRX): Free Stock Analysis Report
 
Agnico Eagle Mines Limited (AEM): Free Stock Analysis Report
 
Evercore Inc (EVR): Free Stock Analysis Report
 
Veeva Systems Inc. (VEEV): Free Stock Analysis Report
 
Bilibili Inc. Sponsored ADR (BILI): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Latest News